Pinilla Lozano, Isabel, Maneu, Victoria, Campello Blasco, Laura, Fernández-Sánchez, Laura, Martínez Gil, Natalia, Kutsyr, Oksana, Sánchez-Sáez, Xavier, Sánchez-Castillo, Carla, Lax, Pedro, Cuenca, Nicolás
Inherited Retinal Dystrophies: Role of Oxidative Stress and Inflammation in Their Physiopathology and Therapeutic Implications
Pinilla I, Maneu V, Campello L, Fernández-Sánchez L, Martínez-Gil N, Kutsyr O, Sánchez-Sáez X, Sánchez-Castillo C, Lax P, Cuenca N. Inherited Retinal Dystrophies: Role of Oxidative Stress and Inflammation in Their Physiopathology and Therapeutic Implications. Antioxidants. 2022; 11(6):1086. https://doi.org/10.3390/antiox11061086
URI: http://hdl.handle.net/10045/124157
DOI: 10.3390/antiox11061086
ISSN: 2076-3921
Abstract: 
Inherited retinal dystrophies (IRDs) are a large group of genetically and clinically heterogeneous diseases characterized by the progressive degeneration of the retina, ultimately leading to loss of visual function. Oxidative stress and inflammation play fundamental roles in the physiopathology of these diseases. Photoreceptor cell death induces an inflammatory state in the retina. The activation of several molecular pathways triggers different cellular responses to injury, including the activation of microglia to eliminate debris and recruit inflammatory cells from circulation. Therapeutical options for IRDs are currently limited, although a small number of patients have been successfully treated by gene therapy. Many other therapeutic strategies are being pursued to mitigate the deleterious effects of IRDs associated with oxidative metabolism and/or inflammation, including inhibiting reactive oxygen species’ accumulation and inflammatory responses, and blocking autophagy. Several compounds are being tested in clinical trials, generating great expectations for their implementation. The present review discusses the main death mechanisms that occur in IRDs and the latest therapies that are under investigation.
Keywords:Inherited retinal dystrophies, Oxidative stress, Inflammation, Reactive oxygen species, Clinical trial
MDPI
info:eu-repo/semantics/article